Evidence map›Paper›PMID 38107122›Full record

ArticleFood science & nutrition2023

Revealing the mechanism of quinoa on type 2 diabetes based on intestinal flora and taste pathways.

Chun-Yan Zheng, Tian An, Zheng-Ting Liang, Bo-Han Lv, Yu-Tong Liu, Xue-Hong Hu, Yue-Lin Zhang, Nan-Nan Liu, Si-Yu Tao, Ru-Xue Deng and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Chun-Yan ZhengTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.
Tian AnSchool of Traditional Chinese Medicine Capital Medical University Beijing China.
Zheng-Ting LiangTraditional Chinese Medicine School Xinjiang Medical University Xinjiang China.
Bo-Han LvTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.
Yu-Tong LiuGansu Pure High-Land Agricultural Science and Technology Limited Company Lanzhou China.
Xue-Hong HuTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.
Yue-Lin ZhangTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.
Nan-Nan LiuTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.
Si-Yu TaoTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.
Ru-Xue DengTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.
Jia-Xian LiuGansu Pure High-Land Agricultural Science and Technology Limited Company Lanzhou China.
Guang-Jian JiangTraditional Chinese Medicine School Beijing University of Chinese Medicine Beijing China.ORCID https://orcid.org/0000-0001-8394-5904
Beijing University of Chinese Medicine · CNGansu Agricultural University · CNCapital Medical University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the antidiabetic effects and mechanisms of quinoa on type 2 diabetes mellitus (T2DM) mice model. In this context, we induced the T2DM mice model with a high-fat diet (HFD) combined with streptozotocin (STZ), followed by treatment with a quinoa diet. To explore the impact of quinoa on the intestinal flora, we predicted and validated its potential mechanism of hypoglycemic effect through network pharmacology, molecular docking, western blot, and immunohistochemistry (IHC). We found that quinoa could significantly improve abnormal glucolipid metabolism in T2DM mice. Further analysis showed that quinoa contributed to the improvement of gut microbiota composition positively. Moreover, it could downregulate the expression of TAS1R3 and TRPM5 in the colon. A total of 72 active components were identified by network pharmacology. Among them, TAS1R3 and TRPM5 were successfully docked with the core components of quinoa. These findings confirm that quinoa may exert hypoglycemic effects through gut microbiota and the TAS1R3/TRPM5 taste signaling pathway.

Indexed as

diabetesintestinal floramolecular dockingnetwork pharmacologyquinoataste receptor

Identifiers

PMID38107122
PMCPMC10724620
OpenAlexW4386980982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.